index - Thérapie génique pour la DMD & physiopathologie du muscle squelettique

Dernières publications

Chiffres clés

53 Publications avec texte intégral

Open Access

75 %

Mots clés

Morphogenesis Gene Expression Regulation/drug effects Clinical trials MES DMD Antisense oligonucleotides Metabolism MiARN Mice Gene modifiers Becker muscular dystrophy BMD Inbred C57BL Muscle cell fusion Duchenne muscular dystrophy Molecular docking Multi resolution modeling Dilated Cardiomyopathy Calcium Dystrophin Mitochondrial fission Exon skipping Cell Line Long QT Invivo Animals Dystrophine Cell homeostasis Male CTNNB1 Allele‐specific silencing therapy Becker muscular dystrophy Long noncoding RNA Dystrophin-EGFP Muscle Energy Metabolism/drug effects Genomic Inhibitors Hear Base Sequence L-Type Multiresolution modeling Dynamin 2 Modificateurs de gènes Humans Dystrophie musculaire de Becker CD38 Cell Biology Inbred mdx Delivery Skeletal muscle Drp1 Gene expression Knockout Animal/physiopathology Autophagy DHPR α1S Muscle hypertrophy LncRNA Duchenne muscular dystrophy DMD Dystrophin central domain Becker muscular dystrophy BMD Duchenne muscular dystrophy DMD miRNA nNOS LKB1 Cardiomyopathy Adult muscle stem cells Diseases Becker Muscular Dystrophy Dystrophy Calcium Channels Molecular Sequence Data Multi exon skipping Cells Dystrophie Musculaire de Becker BMD Centronuclear myopathy Mdx mouse Cachexia Ex-vivo Heart Failure Muscle Strength Hepatocellular carcinoma Dystrophie Musculaire de Duchenne DMD LncARN Cultured Cardiomyopathie Muscle Biology DMO Connexins Activin Receptors Liver BMD Human Umbilical Vein Endothelial Cells Epigenetics CaV subunits Duchenne DMD dystrophy Homeostasis Immunoglobulin Fc Fragments/pharmacology Muscle development Génomique CaVβs Muscle damage Becker BMD muscular dystrophy